Mumbai, November 27, 2017: Pharma Major,Strides Shasun’s said that its wholly owned subsidiary Strides Pharma Global has received approval from the United States Food & Drug Administration (USFDA) for Acetazolamide Tablets USP, 125 mg and 250 mg., a generic version of Diamox Tablets.
The product, to be launched immediately, will be marketed by Strides Pharma Inc. in the US Market. Acetazolamide Tablets is used to prevent and reduce the symptoms of altitude sickness. , company said uin afiling with BSE.
Acetazolamide is also used with other medications to treat a certain type of eye problem (open-angle glaucoma).
According to IMS data, the US market for Acetazolamide Tablets is approximately USD53 million. The approval, which was received in a short span of 11 months, demonstrates company’s strategy of building a niche portfolio in regulated markets, having limited competition.
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…